Exciting times..FDA site/API approval is a massive success for LABs and our global pharmaceutical partners im expecting NDA approval/505b news/details before year end...this FDA approval news is under appreciated because details are withheld for competitive reasons....canopy's asset light model has seen contracts outsourced for vapes, edibles and beverages but nothing YET for oils..I'm hopeful LABs is in the running and furthermore we will see other LPs following suit....considering canopy has shown major improvement on loss since adopting this "asset light" model and the financial state of the industry players, it's hard to imagine others won't follow suit, possibly bringing B2B revenue back from the dead...fact is I got the feeling..can't shake it....don't forget governmental review up Jan...excise tax/health Canada fees slashed?...how could it not?...1$per gram is ludacris...BULLISH...that's how I'm feeling anyways..